Get complete Patent Opposition Report for Abbvie

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Abbvie

Explore patent oppositions filed by Abbvie against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP4058148Dosing Regimen For Anti-Bcma AgentsAMGENDec 13, 2024
EP3177645Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDHOFERNov 17, 2021
EP3616720Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITYNov 16, 2021
EP3153526Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALEJun 21, 2021
EP3219328Human Anti-Il-23 Antibodies, Compositions, Method And UsesJANSSEN BIOTECHMar 17, 2021
EP2978446Methods And Agents For Treating Alzheimer'S DiseaseTHE GENERAL HOSPITALDec 4, 2020
EP2780375Binding Molecules For Bcma And Cd3AMGENMar 6, 2020
EP2654789Antibodies Against Human Cd39 And Use ThereofINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALEFeb 15, 2019
EP2530091Anti-Dll3 AntibodyCHUGAI SEIYAKU KABUSHIKI KAISHAJan 4, 2019

Explore Abbvie's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3377110Jan 6, 2021Nanoparticles Based On Optionally Alkoxylated Poly(Alkyl Cyanoacrylates) Having A Defined Degree Of Polymerization1
EP2691134Oct 7, 2020Improved Shroud Deployment In Automatic Injection Devices1
EP3213750Aug 12, 2020Combination Of Two Antivirals For Treating Hepatitis C1
EP2897611Jul 24, 2019Methods For Treating Hepatitis C1
EP2968302Feb 13, 2019Combination Of Direct Acting Antiviral Agents And Ribavirin For Treating Hcv Patients1
EP2954892Jul 18, 2018Solid Compositions2
EP2957307Jul 18, 2018Automatic Injection Device1
EP2258346Sep 27, 2017Solid Pharmaceutical Dosage Form Comprising An Hiv Protease Inhibitor Solid Dispersion1
EP2643322Aug 30, 2017Salts And Crystalline Forms Of An Apoptosis-Inducing Agent1
EP2506716May 17, 2017Novel Tricyclic Compounds1